Get the Stockscreener App
0.4384
3.77%
0.0164
Biodesix Inc stock is traded at $0.4384, with a volume of 53.02M.
It is up +3.77% in the last 24 hours and up +13.98% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$0.422
Open:
$0.5402
24h Volume:
53.02M
Relative Volume:
37.87
Market Cap:
$64.24M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-0.6745
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
-1.90%
1M Performance:
+13.98%
6M Performance:
-39.18%
1Y Performance:
-76.07%
1-Day Range:
$0.4101
$0.5402
1-Week Range:
$0.4101
$0.5402
52-Week Range:
$0.1718
$1.90
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.4381 | 63.58M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
485.38 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.03 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.80 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
127.39 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.66 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jul-26-24 | Initiated | Craig Hallum | Buy |
| May-13-24 | Initiated | TD Cowen | Buy |
| May-03-24 | Initiated | Lake Street | Buy |
| Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-20 | Initiated | BTIG Research | Buy |
| Nov-23-20 | Initiated | Canaccord Genuity | Buy |
| Nov-23-20 | Initiated | Morgan Stanley | Overweight |
| Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
Merger Talk: Is Biodesix Inc. stock forming a cup and handleJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - khodrobank.com
Biodesix Inc. stock chart pattern explainedPortfolio Gains Report & Stock Timing and Entry Methods - Newser
Custom watchlist performance reports with Biodesix Inc.CEO Change & Weekly Watchlist for Hot Stocks - Newser
Analyzing recovery setups for Biodesix Inc. investorsJuly 2025 Reactions & Long-Term Growth Plans - Newser
Is Biodesix Inc. stock ready for a breakoutEarnings Risk Report & Step-by-Step Trade Execution Guides - Newser
Reversal indicators forming on Biodesix Inc. stock2025 Volume Leaders & Long-Term Growth Stock Strategies - Newser
Sector ETF performance correlation with Biodesix Inc.Earnings Miss & Low Risk High Reward Ideas - Newser
Pattern recognition hints at Biodesix Inc. upsideInsider Selling & Precise Buy Zone Tips - Newser
Exit strategy if you’re trapped in Biodesix Inc.July 2025 WrapUp & Fast Gain Swing Alerts - Newser
Analyzing Biodesix Inc. with multi timeframe chartsEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - Newser
Using Ichimoku Cloud for Biodesix Inc. technicals2025 Retail Activity & AI Driven Price Forecasts - Newser
Statistical indicators supporting Biodesix Inc.’s strengthAnalyst Upgrade & Proven Capital Preservation Tips - Newser
Earnings visualization tools for Biodesix Inc.Share Buyback & AI Powered Market Entry Strategies - Newser
Measuring Biodesix Inc.’s beta against major indicesProfit Target & Stepwise Entry/Exit Trade Alerts - Newser
What indicators show strength in Biodesix Inc.Market Performance Report & Free Fast Entry Momentum Trade Alerts - Newser
Analyzing net buyer seller activity in Biodesix Inc.2025 Short Interest & Growth Oriented Trading Recommendations - Newser
What are analysts’ price targets for Biodesix Inc.July 2025 Price Swings & Short-Term Trading Opportunity Alerts - khodrobank.com
What’s the analyst consensus on Biodesix Inc.July 2025 PreEarnings & Low Risk Investment Opportunities - khodrobank.com
Recovery Setup Building in Biodesix Inc. Experts Say getLinesFromResByArray error: size == 0 - thegnnews.com
Chart overlay techniques for tracking Biodesix Inc.2025 Top Gainers & Daily Profit Maximizing Tips - Newser
What is Biodesix Inc. s 5 year growth outlookEarnings Performance Report & Weekly High Conviction Trade Ideas - khodrobank.com
Can Biodesix Inc. outperform under higher oil pricesJuly 2025 Trends & Accurate Intraday Trading Signals - khodrobank.com
Sentiment Recap: Is Biodesix Inc. a strong growth stockJuly 2025 Summary & Growth Focused Entry Point Reports - khodrobank.com
Is Biodesix Inc. stock forming a cup and handle2025 Market Trends & Reliable Intraday Trade Alerts - khodrobank.com
Order Book Volume Tilts Bullish on Biodesix Inc.2025 Key Highlights & Safe Entry Momentum Tips - beatles.ru
Price momentum metrics for Biodesix Inc. explainedOil Prices & Consistent Growth Equity Picks - Newser
Biodesix Inc.’s Price Action Aligns with Quant Signals getLinesFromResByArray error: size == 0 - thegnnews.com
Does Biodesix Inc. qualify in momentum factor screeningProduct Launch & Accurate Buy Signal Alerts - Newser
Combining price and volume data for Biodesix Inc.Quarterly Portfolio Report & Expert Approved Momentum Trade Ideas - Newser
Is this a good reentry point in Biodesix Inc.Weekly Trend Summary & AI Powered Market Trend Analysis - Newser
Will Biodesix Inc. outperform the market in YEARJuly 2025 Weekly Recap & Verified Trade Idea Suggestions - sundaytimes.kr
Published on: 2025-08-31 00:50:21 - Newser
Biodesix Inc. Enters Reversal Setup in Weekly ChartsWeekly Trend Report & Real-Time Volume Trigger Notifications - beatles.ru
Real time scanner hits for Biodesix Inc. explainedEntry Point & Step-by-Step Swing Trade Plans - Newser
Is a relief rally coming for Biodesix Inc. holdersForecast Cut & Weekly Consistent Profit Watchlists - Newser
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Using economic indicators to assess Biodesix Inc. potentialIPO Watch & Verified Entry Point Detection - Newser
Can machine learning forecast Biodesix Inc. recoveryJuly 2025 Sector Moves & Consistent Profit Trade Alerts - Newser
How Biodesix Inc. stock performs during market volatilityCEO Change & High Return Trade Opportunity Guides - Newser
Tools to monitor Biodesix Inc. recovery probabilityJuly 2025 Closing Moves & Weekly Chart Analysis and Guides - Newser
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biodesix Inc Stock (BDSX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Aug 13 '25 |
Sale |
0.42 |
988 |
411 |
250,794 |
| Hutton Scott | President & CEO |
Aug 13 '25 |
Sale |
0.42 |
3,772 |
1,570 |
728,824 |
| O'Kane Kieran | Chief Commercial Officer |
Aug 13 '25 |
Sale |
0.42 |
476 |
198 |
140,065 |
| Pestano Gary Anthony | Chief Development Officer |
Aug 13 '25 |
Sale |
0.42 |
442 |
184 |
157,878 |
| Vazquez Chris | Chief Accounting Officer |
Aug 13 '25 |
Sale |
0.42 |
228 |
95 |
18,375 |
| SCHULER JACK W | Director |
May 16 '25 |
Buy |
0.27 |
4,000,000 |
1,070,000 |
20,194,935 |
| SCHULER JACK W | Director |
May 19 '25 |
Buy |
0.34 |
723,239 |
246,624 |
20,918,174 |
| Vazquez Chris | Chief Accounting Officer |
May 12 '25 |
Sale |
0.36 |
112 |
40 |
18,113 |
| Vazquez Chris | Chief Accounting Officer |
May 13 '25 |
Sale |
0.35 |
112 |
40 |
18,001 |
| Pestano Gary Anthony | Chief Development Officer |
May 12 '25 |
Sale |
0.36 |
223 |
80 |
157,163 |
3.36%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):